Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Immunocompromised children have a higher risk of developing infections and associated higher rates of mortality and morbidity. Although this group could benefit the most from vaccine administration, specific considerations regarding immunisations are required. This review is a summary of the vaccines that are relevant to the immunocompromised host, covering both live and non-live vaccines. The burden of disease, safety, immunogenicity/effectiveness and specific recommendations for each vaccine are described as well as specific guidelines from different organisations.

Original publication

DOI

10.1016/j.jinf.2016.04.017

Type

Journal article

Journal

The Journal of infection

Publication Date

07/2016

Volume

72 Suppl

Pages

S13 - S22

Addresses

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, OX3 7LE, United Kingdom. Electronic address: marta.valentepinto@paed.ox.ac.uk.

Keywords

Humans, Vaccines, Vaccines, Inactivated, Immunization, Immunocompromised Host, Child, Infant, Practice Guidelines as Topic, Vaccines, Live, Unattenuated, Immunogenicity, Vaccine